| Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk N Božina, V Bradamante, M Lovrić Archives of Industrial Hygiene and Toxicology 60 (2), 217-242, 2009 | 319 | 2009 |
| Genetic polymorphisms of cytochromes P450: CYP2C9, CYP2C19, and CYP2D6 in Croatian population. N Bozina, P Granić, Z Lalić, I Tramisak, M Lovrić, A Stavljenić-Rukavina Croatian medical journal 44 (4), 425-428, 2003 | 172 | 2003 |
| MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression AM Peles, N Bozina, M Sagud, MR Kuzman, M Lovric Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (6), 1439-1444, 2008 | 89 | 2008 |
| Sympathetic cardiovascular and sudomotor functions are frequently affected in early multiple sclerosis M Habek, L Crnošija, M Lovrić, A Junaković, M Krbot Skorić, I Adamec Clinical autonomic research 26, 385-393, 2016 | 56 | 2016 |
| Association between lamotrigine concentrations and ABCB1 polymorphisms in patients with epilepsy M Lovric, N Božina, S Hajnšek, MR Kuzman, D Sporiš, Z Lalic, T Božina, ... Therapeutic drug monitoring 34 (5), 518-525, 2012 | 56 | 2012 |
| Genetic polymorphisms of cytochrome P450 enzymes: CYP2C9, CYP2C19, CYP2D6, CYP3A4, and CYP3A5 in the Croatian population L Ganoci, T Božina, N Mirošević Skvrce, M Lovrić, P Mas, N Božina Drug metabolism and personalized therapy 32 (1), 11-21, 2017 | 42 | 2017 |
| Ethylene glycol poisoning M Lovrić, P Granić, M Čubrilo-Turek, Z Lalić, J Sertić Forensic science international 170 (2-3), 213-215, 2007 | 40 | 2007 |
| Sex-dependent expression of water channel AQP1 along the rat nephron CM Herak-Kramberger, D Breljak, M Ljubojević, M Matokanović, M Lovrić, ... American Journal of Physiology-Renal Physiology 308 (8), F809-F821, 2015 | 35 | 2015 |
| Interaction between ABCG2 421C>A polymorphism and valproate in their effects on steady‐state disposition of lamotrigine in adults with epilepsy I Klarica Domjanović, M Lovrić, V Trkulja, Ž Petelin‐Gadže, L Ganoci, ... British journal of clinical pharmacology 84 (9), 2106-2119, 2018 | 28 | 2018 |
| Autonomic dysfunction in clinically isolated syndrome suggestive of multiple sclerosis L Crnošija, I Adamec, M Lovrić, A Junaković, MK Skorić, I Lušić, M Habek Clinical Neurophysiology 127 (1), 864-869, 2016 | 23 | 2016 |
| The fourth S-adenosylhomocysteine hydrolase deficient patient: Further evidence of congenital miopathy M Ćuk, M Lovrić, K Fumić, SH Mudd, O Vugrek, V Sarnavka, I Barić 6th Conference on Homocysteine Metabolism World Congress on …, 2007 | 20 | 2007 |
| Development and validation of a novel LC-MS/MS method for the simultaneous determination of abemaciclib, palbociclib, ribociclib, anastrozole, letrozole, and fulvestrant in … L Turković, L Bočkor, O Ekpenyong, T Silovski, M Lovrić, S Crnković, ... Pharmaceuticals 15 (5), 614, 2022 | 19 | 2022 |
| Lack of association between polymorphism in ABCC2 gene and response to antiepileptic drug treatment in Croatian patients with epilepsy D Sporis, N Bozina, S Basic, M Lovric, T Babic, I Susak, I Markovic Collegium antropologicum 37 (1), 41-45, 2013 | 19 | 2013 |
| Hemodynamic profile and heart rate variability in hyperadrenergic versus non-hyperadrenergic postural orthostatic tachycardia syndrome L Crnošija, MK Skorić, I Adamec, M Lovrić, A Junaković, A Mišmaš, ... Clinical neurophysiology 127 (2), 1639-1644, 2016 | 18 | 2016 |
| Calcium oxalate urolithiasis in children: urinary promoters/inhibitors and role of their ratios D Turudic, D Batinic, AT Golubic, M Lovric, D Milosevic European journal of pediatrics 175, 1959-1965, 2016 | 17 | 2016 |
| In female rats, ethylene glycol treatment elevates protein expression of hepatic and renal oxalate transporter sat-1 (Slc26a1) without inducing hyperoxaluria D Breljak, H Brzica, I Vrhovac, V Micek, D Karaica, M Ljubojević, ... Croatian medical journal 56 (5), 447-459, 2015 | 17 | 2015 |
| Clinical significance of a CYP2D6 poor metabolizer-a patient with schizophrenia on risperidone treatment N Božina, N Jovanovic, M Lovric, V Medved Therapeutic drug monitoring 30 (6), 748-751, 2008 | 17 | 2008 |
| ABCB1, ABCG2 and CYP2D6 polymorphism effects on disposition and response to long-acting risperidone L Ganoci, V Trkulja, M Živković, T Božina, M Šagud, M Lovrić, N Božina Progress in Neuro-Psychopharmacology and Biological Psychiatry 104, 110042, 2021 | 15 | 2021 |
| Glycine N-Methyltransferase Deficiency: A Member of Dysmethylating Liver Disorders? I Barić, S Erdol, H Saglam, M Lovrić, R Belužić, O Vugrek, HJ Blom, ... JIMD Reports, Volume 31, 101-106, 2016 | 14 | 2016 |
| Effect of cyclosporine on steady-state pharmacokinetics of MPA in renal transplant recipients is not affected by the MPA formulation: analysis based on therapeutic drug … V Trkulja, Z Lalic, S Nad-Škegro, A Lebo, P Granic, M Lovric, J Pasini, ... Therapeutic drug monitoring 36 (4), 456-464, 2014 | 14 | 2014 |
